As cellular therapy products often cross international borders, it is important to be aware of applicable regulations in other regions. Products shipped across international borders must meet regulatory requirements of the competent authority of the exporting and importing country. Information on some non-U.S. competent authorities can be accessed via the links provided below. The information for each country is meant to serve as a resource, not a substitute for regulatory information or legal advice. Additionally, the information on this page is not updated in real-time, please contact the relevant competent authority to receive the most up-to-date information.
StemCyte Introduces Insurance-Linked Cord Blood Access in Taiwan
November 12, 2025
AABB to Join CGT Supply Chain Discussions at Advanced Therapies USA
November 12, 2025
CMS Finalizes 2026 Medicare PFS Rule, Updates Biotherapies Payment Policies
November 05, 2025